CIK 1381843
Atle Fund Management AB
Institutional 13F holdings & portfolio
Holdings
39
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
2
Holdings
13F filings as of Dec 31, 2025 · Showing 1–39 of 39
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| LLY | Eli Lilly & Co | 31K | $1M+ | SH |
| ABBV | AbbVie Inc | 108K | $1M+ | SH |
| MRK | Merck & Co. Inc | 196K | $1M+ | SH |
| TMO | Thermo Fisher Scientific Corp | 30K | $1M+ | SH |
| NBIX | Neurocrine Biosciences Inc | 95K | $1M+ | SH |
| ISRG | Intuitive Surgical Inc | 22K | $1M+ | SH |
| ONC | BEONE MEDICINES LTD-ADR | 40K | $1M+ | SH |
| BBIO | Bridgebio Pharma Inc | 141K | $1M+ | SH |
| VRTX | Vertex Pharmaceuticals Inc | 23K | $1M+ | SH |
| BSX | Boston Scientific Corp | 109K | $1M+ | SH |
| SYK | Stryker Corporation | 27K | $1M+ | SH |
| CVS | CVS HEALTH CORP | 107K | $1M+ | SH |
| KRYS | Krystal Biotech, Inc | 34K | $1M+ | SH |
| COR | Cencora Inc | 24K | $1M+ | SH |
| IONS | IONIS PHARMACEUTICALS INC | 92K | $1M+ | SH |
| RVMD | REVOLUTION Medicines Inc | 90K | $1M+ | SH |
| AMGN | Amgen Inc | 22K | $1M+ | SH |
| MIRM | Mirum Pharmaceuticals Inc | 90K | $1M+ | SH |
| INCY | INCYTE CORP | 71K | $1M+ | SH |
| NAMS | NewAmsterdam Pharma Co NV | 197K | $1M+ | SH |
| ALKS | Alkermes PLC | 242K | $1M+ | SH |
| IRTC | iRhythm Technologies Inc | 38K | $1M+ | SH |
| GILD | Gilead Sciences Inc | 51K | $1M+ | SH |
| UFPT | UFP Technologies Inc | 23K | $1M+ | SH |
| INSM | INSMED INC | 28K | $1M+ | SH |
| CAH | Cardinal Health Inc | 23K | $1M+ | SH |
| ABVX | ABIVAX SA | 32K | $1M+ | SH |
| CELC | CELCUITY INC | 42K | $1M+ | SH |
| IRON | Disc medicine inc | 48K | $1M+ | SH |
| IDYA | IDEAYA BIOSCIENCES INC | 97K | $1M+ | SH |
| UNH | Universal Health Services Inc | 15K | $1M+ | SH |
| CMPX | COMPASS THERAPEUTICS INC | 584K | $1M+ | SH |
| SLNO | Soleno Therapeutics Inc | 63K | $1M+ | SH |
| ACLX | Arcellx Inc | 42K | $1M+ | SH |
| DXCM | Dexcom Inc | 40K | $1M+ | SH |
| AUTL | Autolus Therapeutics PLC | 1.2M | $1M+ | SH |
| BCAX | BICARA THERAPEUTICS INC | 111K | $1M+ | SH |
| CRBP | Corbus Pharmaceuticals Holding | 107K | $500K+ | SH |
| PYXS | PYXIS ONCOLOGY INC | 617K | $500K+ | SH |